RedHill Biopharma Announces Closing of $25 Million Bought Deal Offering

By Business Insider5 days ago

AD

TEL AVIV, Israel and RALEIGH, N.C., Jan. 14, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill“ or the “Company“), a specialty biopharmaceutical company, today announced the closing of its previously announced...

Continue read on businessinsider.com